Therefore, our team hypothesized that targeted regulation of VEGF-C and CCR7 may become a novel therapeutic option for the prevention and treatment of brain metastasis via lymphatic route in patients with hepatocellular carcinoma in the future. Here, VEGFC is linked to hepatocellular carcinoma.